Location History:
- Hyogo, JP (1999)
- Amagasaki, JP (2000)
Company Filing History:
Years Active: 1999-2000
Title: Shigehiro Higuchi: Innovator in Pharmaceutical Technologies
Introduction
Shigehiro Higuchi is a notable inventor based in Amagasaki, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative methods for drug formulation. With a total of 2 patents to his name, Higuchi's work has the potential to enhance drug delivery systems and improve patient outcomes.
Latest Patents
Higuchi's latest patents include a method for producing microparticles and a freeze-dried preparation for pharmaceutical use. The method for producing microparticles involves pulverizing a solid preparation that includes a specific compound and a biodegradable polymer. This innovative approach results in microparticles that are less adhesive and exhibit reduced aggregation, thereby improving drug entrapment ratios and allowing for controlled drug release in desired particle sizes. The freeze-dried preparation comprises a bioactive substance with an amidino group and a disaccharide that stabilizes the bioactive substance, along with a process for making this preparation.
Career Highlights
Shigehiro Higuchi is currently associated with Takeda Chemical Industries, Inc., a leading pharmaceutical company. His work at Takeda has allowed him to focus on developing advanced pharmaceutical formulations that address various medical needs. His contributions have been instrumental in pushing the boundaries of drug delivery technologies.
Collaborations
Higuchi has collaborated with notable colleagues such as Nobuyuki Takechi and Muneo Nonomura. These collaborations have fostered a creative environment that encourages innovation and the sharing of ideas, further enhancing the impact of their collective work in the pharmaceutical industry.
Conclusion
Shigehiro Higuchi's innovative contributions to pharmaceutical technologies demonstrate his commitment to improving drug delivery systems. His patents reflect a deep understanding of the complexities involved in drug formulation, and his work continues to influence the field positively.